Bausch Health Companies (BHC) - Stock & Dividends

Bausch Health Companies Inc., listed on the NYSE as BHC, is a diverse pharmaceutical firm that not only develops but also manufactures and markets a wide array of products in various healthcare fields. These fields include gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, and eye health. The company operates through five distinct segments to cater to different aspects of the medical market: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.

The Salix segment focuses on providing gastroenterology products within the United States, whereas the International segment specializes in selling aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products on a global scale. The Solta Medical segment, on the other hand, is dedicated to the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in neurology and other therapeutic areas, generic products, ortho dermatologic products, and dentistry products specifically within the United States.

Bausch + Lomb, another segment of the company, concentrates on delivering products related to vision care, surgical procedures, and ophthalmic pharmaceuticals. Initially known as Valeant Pharmaceuticals International, Inc., the company rebranded to Bausch Health Companies Inc. in July 2018. Founded in 2013, Bausch Health Companies Inc. is headquartered in Laval, Canada. To learn more, visit their website at https://www.bauschhealth.com.